PLEKHG5 regulates autophagy, survival and MGMT expression in U251-MG glioblastoma cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
PLEKHG5 regulates autophagy, survival and MGMT expression in U251-MG glioblastoma cells ; volume:10 ; number:1 ; day:14 ; month:12 ; year:2020 ; pages:1-19 ; date:12.2020
Scientific reports ; 10, Heft 1 (14.12.2020), 1-19, 12.2020
- Creator
-
Witte, Kaya Elisa
Slotta, Carsten
Lütkemeyer, Melanie
Kitke, Angelika
Coras, Roland
Simon, Matthias
Kaltschmidt, Christian
Kaltschmidt, Barbara
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-020-77958-3
- URN
-
urn:nbn:de:101:1-2021011608423953116493
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Witte, Kaya Elisa
- Slotta, Carsten
- Lütkemeyer, Melanie
- Kitke, Angelika
- Coras, Roland
- Simon, Matthias
- Kaltschmidt, Christian
- Kaltschmidt, Barbara
- SpringerLink (Online service)
Other Objects (12)
A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma
Hedgehog/Gli1 signaling pathway regulates MGMT expression and chemoresistance to temozolomide in human glioblastoma
MGMT methylation and its prognostic significance in inoperable IDH-wildtype glioblastoma: the MGMT-GBM study
Volumetric and MGMT parameters in glioblastoma patients: Survival analysis
MGMT inhibition regulates radioresponse in GBM, GSC, and melanoma
Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma
Stanniocalcin-1 promotes temozolomide resistance of glioblastoma through regulation of MGMT
MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma
Mitochondria‐Targeted Temozolomide Probe for Overcoming MGMT‐Mediated Resistance in Glioblastoma
Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma
Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patients
Molecular targeting of autophagy in glioblastoma
A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma
Hedgehog/Gli1 signaling pathway regulates MGMT expression and chemoresistance to temozolomide in human glioblastoma
MGMT methylation and its prognostic significance in inoperable IDH-wildtype glioblastoma: the MGMT-GBM study
Volumetric and MGMT parameters in glioblastoma patients: Survival analysis
MGMT inhibition regulates radioresponse in GBM, GSC, and melanoma
Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma
Stanniocalcin-1 promotes temozolomide resistance of glioblastoma through regulation of MGMT
MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma
Mitochondria‐Targeted Temozolomide Probe for Overcoming MGMT‐Mediated Resistance in Glioblastoma
Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma
Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patients
Molecular targeting of autophagy in glioblastoma
A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma
Hedgehog/Gli1 signaling pathway regulates MGMT expression and chemoresistance to temozolomide in human glioblastoma
MGMT methylation and its prognostic significance in inoperable IDH-wildtype glioblastoma: the MGMT-GBM study
Volumetric and MGMT parameters in glioblastoma patients: Survival analysis
MGMT inhibition regulates radioresponse in GBM, GSC, and melanoma
Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma
Stanniocalcin-1 promotes temozolomide resistance of glioblastoma through regulation of MGMT
MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastoma
Mitochondria‐Targeted Temozolomide Probe for Overcoming MGMT‐Mediated Resistance in Glioblastoma
Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma
Predictive MGMT status in a homogeneous cohort of IDH wildtype glioblastoma patients